Clinical results of long-term peritoneal dialysis (PD) therapy in patients with liver cirrhosis (LC) and end-stage renal disease (ESRD) are controversial. This study evaluated the clinical outcomes of LC patients undergoing PD.
Methods
Clinical records were retrospectively collected from a single center between January 2007 and December 2014. An analysis of PD patients with LC and without liver disease was performed using propensity score matching. We further restricted matching by age, gender, and the presence of diabetes mellitus. Two cohorts of 33 patients each were selected. Early technical complications were defined as the presence of catheter-related complications, including malposition, leakage, omental wrapping, obstruction, and requiring a transfer to hemodialysis (HD) within 6 months of initiating PD.
Results
Mean PD duration was lower in LC patients (57.2 ± 46.1 months) than in controls (85.8 ± 64.2 months). Blood urea nitrogen, creatinine, and albumin levels were significantly lower in LC patients than in the control group. Cystatin C and cystatin C-based glomerular filtration rates were not significantly different in the LC group compared with those in the controls. We found that the risks for early technical complications, peritonitis, and long-term PD and patient survival were not higher in patients with LC than in those without LC. Ascites were easily controlled, and hepatic encephalopathy did not affect PD maintenance in LC patients.
Conclusions
The clinical outcomes, including technical complications, peritonitis, and patients’ survival, suggest that PD can be used as a renal replacement therapy in ESRD patients with LC.
FedeG., D'AmicoG., ArvanitiV., TsochatzisE., GermaniG., GeorgiadisD.Renal failure and cirrhosis: a systematic review of mortality and prognosis.J Hepatol2012; 56: 810–8.
ChoiY.J., KimJ.H., KooJ.K., LeeC.I., LeeJ.Y., YangJ.H.Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal.Clin Mol Hepatol2014; 20: 185–91.
4.
JangJ.W.Current status of liver diseases in Korea: liver cirrhosis.Korean J Hepatol2009; 15(Suppl 6): S40–9.
5.
de CarvalhoJ.R., Villela-NogueiraC.A., LuizR.R., GuzzoP.L., da Silva RosaJ.M., RochaE.Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites.J Clin Gastroenterol2012; 46: e21–6.
6.
KungH.C., HoyertD.L., XuJ., MurphyS.L.Deaths: final data for 2005.Natl Vital Stat Rep2008; 56: 1–120.
DavenportA., WillE.J., DavisonA.M.Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure.Nephrol Dial Transplant1990; 5: 192–8.
9.
DavenportA., WillE.J., DavisonA.M., SwindellsS., CohenA.T., MiloszewskiK.J.Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy.Nephron1989; 53: 142–6.
10.
DonovanJ.P., SchaferD.F., ShawB.W.Jr., SorrellM.F.Cerebral oedema and increased intracranial pressure in chronic liver disease.Lancet1998; 351: 719–21.
11.
ChristouL., PappasG., FalagasM.E.Bacterial infection-related morbidity and mortality in cirrhosis.Am J Gastroenterol2007; 102: 1510–7.
12.
DavenportA.Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003.Perit Dial Int2009; 29: 297–302.
13.
MarcusR.G., MessanaJ., SwartzR.Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites.Am J Med1992; 93: 35–40.
14.
SelgasR., BajoM.A., JimenezC., SanchezC., Del PesoG., CachoG.Peritoneal dialysis in liver disorders.Perit Dial Int1996; 16(Suppl 1): S215–9.
15.
De VecchiA.F., ColucciP., SalernoF., ScalamognaA., PonticelliC.Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure.Am J Kidney Dis2002; 40: 161–8.
16.
KreuzerM., GahlerD., RakeniusA.C., PrufeJ., JackT., PfisterE.D.Dialysis-dependent acute kidney injury in children with end-stage liver disease: prevalence, dialysis modalities and outcome.Pediatr Nephrol2015; 30: 2199–206.
17.
PughR.N., Murray-LyonI.M., DawsonJ.L., PietroniM.C., WilliamsR.Transection of the oesophagus for bleeding oesophageal varices.Br J Surg1973; 60: 646–9.
18.
WaradyB.A., BakkalogluS., NewlandJ., CantwellM., VerrinaE., NeuA.Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.Perit Dial Int2012; 32(Suppl 2): S32–86.
19.
MoistL.M., PortF.K., OrzolS.M., YoungE.W., OstbyeT., WolfeR.A.Predictors of loss of residual renal function among new dialysis patients.J Am Soc Nephrol2000; 11: 556–64.
20.
SelgasR., BajoM.A., Del PesoG., Sanchez-VillanuevaR., GonzalezE., RomeroS.Peritoneal dialysis in the comprehensive management of end-stage renal disease patients with liver cirrhosis and ascites: practical aspects and review of the literature.Perit Dial Int2008; 28: 118–22.
LeeS.M., NamH.S., JeongE.G., SonY.K., KimS.E., AnW.S.Comparison of exit-site infection and peritonitis incidences between povidone-iodine and normal saline use for chronic exit-site care in peritoneal dialysis patients.Kidney Res Clin Pract2014; 33: 144–9.
23.
BurkeM., HawleyC.M., BadveS.V., McDonaldS.P., BrownF.G., BoudvilleN.Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study.Am J Kidney Dis2011; 58: 429–36.
SewellD.L., GolperT.A., HulmanP.B., ThomasC.M., WestL.M., KubeyW.Y.Comparison of large volume culture to other methods for isolation of microorganisms from dialysate.Perit Dial Int1990; 10: 49–52.
27.
AzapO.K., TimurkaynakF., SezerS., CagirU., YaparG., ArslanH.Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis.Transplant Proc2006; 38: 411–2.
28.
von GraevenitzA., AmsterdamD.Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis.Clin Microbiol Rev1992; 5: 36–48.
29.
AfsarB., ElsurerR., BilgicA., SezerS., OzdemirF.Regular lactulose use is associated with lower peritonitis rates: an observational study.Perit Dial Int2010; 30: 243–6.
30.
SegaertM., CarlierB., VerbanckJ.Recurrent hepatic coma in a chronic hemodialysis patient: successful treatment by CAPD.Perit Dial Int1984; 4.
31.
ParaisoV., FrancosM., Rodriguez-BerzosaF., FelipeC., Lopez-ValdesE., MartinR.Portosystemic encephalopathy in a patient treated with peritoneal dialysis.Am J Kidney Dis2007; 49: 854–8.
32.
KozS., SahinI., TerziZ., KozS.T.Course of encephalopathy in a cirrhotic dialysis patient treated sequentially with peritoneal and hemodialysis.Case Rep Med2015; 2015: 375456.
33.
TizianelloA., GaribottoG., RobaudoC., SaffiotiS., PontremoliR., BruzzoneM.Renal ammoniagenesis in humans with chronic potassium depletion.Kidney Int1991; 40: 772–8.
34.
HeafJ.G., LokkegaardH., MadsenM.Initial survival advantage of peritoneal dialysis relative to haemodialysis.Nephrol Dial Transplant2002; 17: 112–7.
35.
SchaubelD.E., MorrisonH.I., FentonS.S.Comparing mortality rates on CAPD/ CCPD and hemodialysis. The Canadian experience: fact or fiction?Perit Dial Int1998; 18: 478–84.
36.
ChienC.C., WangJ.J., SunY.M., SunD.P., SheuM.J., WengS.F.Long-term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: a national cohort study in Taiwan.BMC Nephrol2012; 13: 43.
